Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T46216 | Target Info | |||
Target Name | Bromodomain-containing protein 9 (BRD9) | ||||
Synonyms | Rhabdomyosarcoma antigen MU-RMS-40.8 | ||||
Target Type | Literature-reported Target | ||||
Gene Name | BRD9 | ||||
Biochemical Class | Bromodomain | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | I-BRD9 | Ligand Info | |||
Canonical SMILES | CCN1C=C(C2=C(C1=O)C=C(S2)C(=NC3CCS(=O)(=O)CC3)N)C4=CC(=CC=C4)C(F)(F)F | ||||
InChI | 1S/C22H22F3N3O3S2/c1-2-28-12-17(13-4-3-5-14(10-13)22(23,24)25)19-16(21(28)29)11-18(32-19)20(26)27-15-6-8-33(30,31)9-7-15/h3-5,10-12,15H,2,6-9H2,1H3,(H2,26,27) | ||||
InChIKey | WRUWGLUCNBMGPS-UHFFFAOYSA-N | ||||
PubChem Compound ID | 91668541 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6V1B Crystal structure of the bromodomain of human BRD9 bound to I-BRD9 | ||||||
Method | X-ray diffraction | Resolution | 1.35 Å | Mutation | No | [1] |
PDB Sequence |
ESTPIQQLLE
146 HFLRQLQRKD156 PHGFFAFPVT166 DAIAPGYSMI176 IKHPMDFGTM186 KDKIVANEYK 196 SVTEFKADFK206 LMCDNAMTYN216 RPDTVYYKLA226 KKILHAGFKM236 MSKERLLALK 246 RSMS
|
|||||
|
||||||
PDB ID: 4UIW BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | ||||||
Method | X-ray diffraction | Resolution | 1.73 Å | Mutation | No | [2] |
PDB Sequence |
STPIQQLLEH
31 FLRQLQRKDP41 HGFFAFPVTD51 AIAPGYSMII61 KHPMDFGTMK71 DKIVANEYKS 81 VTEFKADFKL91 MCDNAMTYNR101 PDTVYYKLAK111 KILHAGFKMM121 S |
|||||
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structural Basis of Inhibitor Selectivity in the BRD7/9 Subfamily of Bromodomains. J Med Chem. 2020 Mar 26;63(6):3227-3237. | ||||
REF 2 | Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition. J Med Chem. 2016 Feb 25;59(4):1425-39. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.